| For: | Fiorino S, Bacchi-Reggiani ML, Visani M, Acquaviva G, Fornelli A, Masetti M, Tura A, Grizzi F, Zanello M, Mastrangelo L, Lombardi R, Di Tommaso L, Bondi A, Sabbatani S, Domanico A, Fabbri C, Leandri P, Pession A, Jovine E, de Biase D. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World J Gastroenterol 2016; 22(15): 3907-3936 [PMID: 27099435 DOI: 10.3748/wjg.v22.i15.3907] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v22/i15/3907.htm |
| Number | Citing Articles |
| 1 |
Shalini R. Dubey, Tester F. Ashavaid, Philip Abraham, Minal Umesh Paradkar. Factors influencing circulating microRNAs as biomarkers for liver diseases. Molecular Biology Reports 2022; 49(6) doi: 10.1007/s11033-022-07170-1
|
| 2 |
Fei Yuan, Zhandong Li, Lei Chen, Tao Zeng, Yu-Hang Zhang, Shijian Ding, Tao Huang, Yu-Dong Cai. Identifying the Signatures and Rules of Circulating Extracellular MicroRNA for Distinguishing Cancer Subtypes. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.651610
|
| 3 |
Melanie Tepus, Tung On Yau. Non-Invasive Colorectal Cancer Screening: An Overview. Gastrointestinal Tumors 2020; 7(3) doi: 10.1159/000507701
|
| 4 |
Ye Cao, Jiajia Zheng, Chentao Lv. Retracted Article: miR-199a-3p knockdown inhibits dedifferentiated liposarcoma (DDLPS) cell viability and enhances apoptosis through targeting casein kinase-1 alpha (CK1α). RSC Advances 2019; 9(39) doi: 10.1039/C9RA01491H
|
| 5 |
Sven H. Loosen, Theresa H. Wirtz, Sanchari Roy, Mihael Vucur, Mirco Castoldi, Anne T. Schneider, Christiane Koppe, Tom F. Ulmer, Anjali A. Roeth, Jan Bednarsch, Patrick H. Alizai, Pia Paffenholz, Münevver Demir, Christian Trautwein, Frank Tacke, Ulf P. Neumann, Christoph Roderburg, Tom Luedde, Matias A Avila. Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma. PLOS ONE 2020; 15(9) doi: 10.1371/journal.pone.0239386
|
| 6 |
. 2018; doi: 10.70675/06aa1dd6z0c89z4f44z80ecz3970b09cbce1
|
| 7 |
Sandeep Kumar, Darian Williams, Sanjoli Sur, Jun-Yao Wang, Hanjoong Jo. Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis. Vascular Pharmacology 2019; 114 doi: 10.1016/j.vph.2018.10.001
|
| 8 |
Xiaomei Wang, Xiaoyu Wen, Jingjing Zhou, Yue Qi, Ruihong Wu, Yao Wang, Yiwen Kui, Rui Hua, Qinglong Jin, Aftab A. Ansari. MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients. PLOS ONE 2017; 12(9) doi: 10.1371/journal.pone.0184292
|
| 9 |
Sheng Zhang, Lizhu Chen, Yafeng Wang, Weifeng Tang, Yu Chen, Longgen Liu.
Investigation of the Association of
miRNA-499
,
miRNA-146a
,
miRNA-196a2
Loci with Hepatocellular Carcinoma Risk: A Case–Control Study Involving 1507 Subjects
. DNA and Cell Biology 2020; 39(3) doi: 10.1089/dna.2019.5145
|
| 10 |
Chen Xue, Xinyu Gu, Zhengyi Bao, Yuanshuai Su, Juan Lu, Lanjuan Li. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.847728
|
| 11 |
Rui Zhang, Li‑Jie Zhang, Mei‑Ling Yang, Lan‑Shan Huang, Gang Chen, Zhen‑Bo Feng. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.8167
|
| 12 |
Yong Gao, Juan Gu, Yueping Wang, Decai Fu, Wensheng Zhang, Guofu Zheng, Xuedong Wang. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137. Pathology - Research and Practice 2020; 216(6) doi: 10.1016/j.prp.2020.152981
|
| 13 |
Yanan Song, Guoyu Wang, Juhua Zhuang, Jing Ni, Suiliang Zhang, Ying Ye, Wei Xia. MicroRNA‑584 prohibits hepatocellular carcinoma cell proliferation and invasion by directly targeting BDNF. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10424
|
| 14 |
Yao Xian, Liang Wang, Bowen Yao, Wei Yang, Huanye Mo, Lei Zhang, Kangsheng Tu. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP. Biomedicine & Pharmacotherapy 2019; 118 doi: 10.1016/j.biopha.2019.109343
|
| 15 |
Junyan Tao, Lili Jiang, Xin Chen. Roles of microRNA in liver cancer. Liver Research 2018; 2(2) doi: 10.1016/j.livres.2018.06.002
|
| 16 |
Sirio Fiorino, Salomone Di Saverio, Paolo Leandri, Andrea Tura, Chiara Birtolo, Mauro Silingardi, Dario de Biase, Eli Avisar. The Role of Matricellular Proteins and Tissue Stiffness in Breast Cancer: A Systematic Review. Future Oncology 2018; 14(16) doi: 10.2217/fon-2017-0510
|
| 17 |
Tengyue Hu, Chang Hai Liu, Yurong Zheng, Jialin Ji, Yantong Zheng, Si-Ke He, Dongbo Wu, Wei Jiang, Qingmin Zeng, Nannan Zhang, Hong Tang. miRNAs in patients with alcoholic liver disease: a systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology 2024; 18(6) doi: 10.1080/17474124.2024.2374470
|
| 18 |
Yahui Liu, Wei Zhang, Songyang Liu, Kai Liu, Bai Ji, Yingchao Wang. miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma. Oncology Reports 2017; 37(3) doi: 10.3892/or.2017.5423
|
| 19 |
Yi-Huan Luo, Wei Tang, Xin Zhang, Zhong Tan, Wen-Liang Guo, Na Zhao, Si-Min Pang, Yi-Wu Dang, Min-Hua Rong, Ji Cao. Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma. Medicine 2017; 96(30) doi: 10.1097/MD.0000000000007545
|
| 20 |
Peng Zhang, Jingda Yu, Yifang Gui, Cui Sun, Weiping Han. Inhibition of miRNA-222-3p Relieves Staphylococcal Enterotoxin B-Induced Liver Inflammatory Injury by Upregulating Suppressors of Cytokine Signaling 1. Yonsei Medical Journal 2019; 60(11) doi: 10.3349/ymj.2019.60.11.1093
|
| 21 |
Ana Karla da Silva Freire, Taciana Furtado de Mendonça Belmont, Edgo Jackson Pinto Santiago, Isabela Cristina Cordeiro Farias, Kleyton Palmeira do Ó, Andreia Soares da Silva, Luydson Richardson Silva Vasconcelos. Potential role of circulating miR-21 in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Expert Review of Molecular Diagnostics 2022; 22(11) doi: 10.1080/14737159.2022.2145189
|
| 22 |
Snežana Jovanović-Ćupić, Milena Krajnović, Lidija Todorović, Ana Božović, Daniel Galun. HCV-Induced Hepatocarcinogenesis: Molecular Mechanisms, Persistent Cancer Risk, and Future Perspectives. Biomedicines 2026; 14(6) doi: 10.3390/biomedicines14061295
|
| 23 |
Elham Karimi, Aghdas Dehghani, Hanieh Azari, Mahboobeh Zarei, Mohammad Shekari, Pegah Mousavi. Molecular Mechanisms of miR-214 Involved in Cancer and Drug
Resistance. Current Molecular Medicine 2023; 23(7) doi: 10.2174/1566524022666220428112744
|
| 24 |
Hang Tuo, Yufeng Wang, Liang Wang, Bowen Yao, Qing Li, Cong Wang, Zhikui Liu, Shaoshan Han, Guozhi Yin, Kangsheng Tu, Qingguang Liu. MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma. Oncotarget 2017; 8(39) doi: 10.18632/oncotarget.20058
|
| 25 |
Camelia Sultana, Adelina Rosca, Simona Ruta. Correlation Between miR-125b Expression and Liver Fibrosis in Patients with Chronic Hepatitis C. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.84615
|
| 26 |
Moamena S. El-Hamouly, Ayman A. Azzam, Samar E. Ghanem, Fathia I. EL-Bassal, Nashwa Shebl, Amira M. F. Shehata. Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma. Molecular Biology Reports 2019; 46(6) doi: 10.1007/s11033-019-05009-w
|
| 27 |
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
|
| 28 |
M. Cahová, H. Daňková, M. Heczková, M. Brátová, N. Ďásková, H. Baštová, J. Gojda, P. Wohl. MicroRNAs as potential markers of parenteral nutrition associated liver disease in adult patients. Physiological Research 2019; doi: 10.33549/physiolres.934103
|
| 29 |
Li Zhang, Chunmei Wang, Xiaojie Lu, Xiao Xu, Tieliu Shi, Jinlian Chen. Transcriptome sequencing of hepatocellular carcinoma uncovers multiple types of dysregulated ncRNAs. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.927524
|
| 30 |
Mirza Ali Nazarnezhad, Mahdi Barazesh, Soudabeh Kavousipour, Shiva Mohammadi, Ebrahim Eftekhar, Sajad Jalili. The Computational Analysis of Single Nucleotide Associated with MicroRNA
Affecting Hepatitis B Infection. MicroRNA 2022; 11(2) doi: 10.2174/2211536611666220509103724
|
| 31 |
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis. Viruses 2022; 14(8) doi: 10.3390/v14081776
|
| 32 |
Muhammad Safdar, Sana Zaheer, Rozhgar A. Khailany, Sadaf Parvez, Muhammad Naveed, Piplu Bhuiyan, Mehmet Ozaslan, Rebaz Moatasam, Mustafa S. Al-Attar, Musarrat Abbas Khan, Yasmeen Junejo. The Relevance of SNPs at 3′UTR Region of CASP7 and miR-371b-5p Associated Diseases: A Computational Analysis. Cell Biochemistry and Biophysics 2020; 78(4) doi: 10.1007/s12013-020-00941-2
|
| 33 |
Fangfang Jiang, Qiaoyun Huang, Jiexiang Nian, Shenghui Yang. miR-221/222/PUMA Axis Promotes Oral Squamous Cell Carcinoma Apoptosis. Open Journal of Stomatology 2023; 13(10) doi: 10.4236/ojst.2023.1310030
|
| 34 |
Fuat Aksoy, Secil Ak Aksoy, Halit Ziya Dundar, Berrin Tunca, Melis Ercelik, Çagla Tekin, Murat Kıyıcı, Kerem Selimoglu, Ekrem Kaya. Blood-Based Biomarkers in Afp Normal/Stable Hepatocellular Carcinoma: Diagnostic and Prognostic Relevance of Mir-10b for Patients on Liver Transplant List. Transplantation Proceedings 2022; 54(7) doi: 10.1016/j.transproceed.2022.05.024
|
| 35 |
Junqi You, Haoming Xia, Ziyue Huang, Risheng He, Xudong Zhao, Jiali Chen, Sidi Liu, Yi Xu, Yunfu Cui. Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1204715
|
| 36 |
Sofi Damjanovska, Hawwa Alao, Elizabeth Zebrowski, Corinne Kowal, Lenche Kostadinova, Perica Davitkov, Yngve Falck-Ytter, Carey L. Shive, Michael Cartwright, Brian Richardson, David Wald, Mark Cameron, Saba Valadkhan, Donald D. Anthony. During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study. Biology 2022; 11(9) doi: 10.3390/biology11091262
|
| 37 |
Marina Manea, Dimitri Apostol, Ileana Constantinescu. The Connection between MiR-122 and Lymphocytes in Patients Receiving Treatment for Chronic Hepatitis B Virus Infection. Microorganisms 2023; 11(11) doi: 10.3390/microorganisms11112731
|
| 38 |
Elodie Miquelestorena‐Standley, Anne Tallet, Christine Collin, Eric Piver, Anne De Muret, Ephrem Salamé, Pascal Bourlier, Thibault Kervarrec, Serge Guyétant, Jean‐Christophe Pagès. Interest of variations in microRNA‐152 and ‐122 in a series of hepatocellular carcinomas related to hepatitis C virus infection. Hepatology Research 2018; 48(7) doi: 10.1111/hepr.12915
|
| 39 |
Bo Du, Peng Zhang, Zhiming Tan, Jifan Xu. MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14. Biomedicine & Pharmacotherapy 2017; 96 doi: 10.1016/j.biopha.2017.11.090
|
| 40 |
Mariano Carossino, Pouya Dini, Theodore S. Kalbfleisch, Alan T. Loynachan, Igor F. Canisso, Kathleen M. Shuck, Peter J. Timoney, R. Frank Cook, Udeni B. R. Balasuriya, Tom Gallagher. Downregulation of MicroRNA eca-mir-128 in Seminal Exosomes and Enhanced Expression of CXCL16 in the Stallion Reproductive Tract Are Associated with Long-Term Persistence of Equine Arteritis Virus. Journal of Virology 2018; 92(9) doi: 10.1128/JVI.00015-18
|
| 41 |
Hu Zongqiang, Chen Jiapeng, Zhao Yingpeng, Yan Chuntao, Wang Yiting, Zhu Jiashun, Li Li, Jingang Huang. Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3. Journal of Immunology Research 2022; 2022 doi: 10.1155/2022/1032106
|
| 42 |
Prognostic and Therapeutic Potentials of OncomiRs Modulating mTOR Pathways in Virus-Associated Hepatocellular Carcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.604540
|
| 43 |
Dipu Bharali, Basu D. Banerjee, Mausumi Bharadwaj, Syed A. Husain, Premashis Kar. Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2019; 9(3) doi: 10.1016/j.jceh.2018.07.005
|
| 44 |
Yang An, Song Gao, Wen-Chao Zhao, Bao-An Qiu, Nian-Xin Xia, Peng-Jun Zhang, Zhen-Ping Fan. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(24): 2596-2604 doi: 10.3748/wjg.v24.i24.2596
|
| 45 |
Ying Ma, Ming Ma, Ling Ma, Fengbo Zhang, Yumei Liu, Xiumin Ma. Downregulation of miR‑552 in hepatocellular carcinoma inhibits cell migration and invasion, and promotes cell apoptosis via RUNX3. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8061
|
| 46 |
Areeg M. Dabbish, Hana M. Abdelzaher, Moustafa Abohawya, Samir Shamma, Yosra H. Mahmoud, Amr Maged, Mohamed Manaa, Mohamed Hassany, Firas Kobeissy, Omid Bazgir, Hassan El-Fawal, Hassan M. E. Azzazy, Anwar Abdelnaser. Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation. Cancers 2022; 14(13) doi: 10.3390/cancers14133036
|
| 47 |
H.Z. Dundar, F. Aksoy, S. Ak Aksoy, P. Tasar, N. Ugras, B. Tunca, U. Egeli, G. Cecener, O. Yerci, E. Kaya. Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus–Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation. Transplantation Proceedings 2019; 51(4) doi: 10.1016/j.transproceed.2019.01.089
|
| 48 |
Sukumaran Sanjay, Chandrashekaran Girish. Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury. European Journal of Clinical Pharmacology 2017; 73(4) doi: 10.1007/s00228-016-2183-1
|
| 49 |
Xiaogang Dong, Wei Ding, Jianwei Ye, Dong Yan, Feng Xue, Lin Xu, Jiwei Yin, Wenjia Guo. MiR‐24‐3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M. Cell Biochemistry and Function 2016; 34(7) doi: 10.1002/cbf.3213
|
| 50 |
J. M. John Britto, T Beula Bell. A systematic review of MicroRNA (miRNA) biomarkers in the diagnosis and prognosis of hepatocellular carcinoma. Irish Journal of Medical Science (1971 -) 2026; 195(2) doi: 10.1007/s11845-025-04162-5
|
| 51 |
Ganghua Yang, Qinhong Xu, Yong Wan, Lei Zhang, Lin Wang, Fandi Meng. Circ-CSPP1 knockdown suppresses hepatocellular carcinoma progression through miR-493-5p releasing-mediated HMGB1 downregulation. Cellular Signalling 2021; 86 doi: 10.1016/j.cellsig.2021.110065
|
| 52 |
Yi Zhang, Wei-Long Hong, Zhi-Ming Li, Qi-Yu Zhang, Kang Zeng. The Mechanism of miR-222 Targets Matrix Metalloproteinase 1 in Regulating Fibroblast Proliferation in Hypertrophic Scars. Aesthetic Plastic Surgery 2021; 45(2) doi: 10.1007/s00266-020-01727-w
|